In breast cancer, MOR is associated with pro‐tumor activity via various pathways including interactions with glycogen synthase kinase 3, a multifunctional serine/threonine protein kinase whose aberrant expression contributes to progression of various disease processes including cancer.23, 24. This evidence concerns the gene OPRM1 and cancer.